Are GSTM1, GSTT1 and CAG repeat length of androgen receptor gene polymorphisms associated with risk of prostate cancer in Iranian patients?
about
GSTP1 Ile105Val polymorphism and prostate cancer risk: evidence from a meta-analysisAssociation between polymorphic CAG repeat lengths in the androgen receptor gene and susceptibility to prostate cancer: A systematic review and meta-analysisAssociation of GSTM1 null allele with prostate cancer risk: evidence from 36 case-control studies.Genetic polymorphisms of GSTM1, GSTT1, and GSTP1 with prostate cancer risk: a meta-analysis of 57 studiesSignificant association of Glutathione S-transferase T1 null genotype with prostate cancer risk: a meta-analysis of 26,393 subjects.GSTT1 polymorphism and the risk of developing prostate cancer.Systematic review and meta-analysis of candidate gene association studies of lower urinary tract symptoms in men.GSTM1 Gene Polymorphism is Implicated in Increased Susceptibility to Prostate Cancer in Caucasians and Asians.Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.GSTT1 Null Genotype Significantly Increases the Susceptibility to Urinary System Cancer: Evidences from 63,876 Subjects.Androgen receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.GSTT1 and GSTM1 polymorphisms and prostate cancer risk in Asians: a systematic review and meta-analysis.Association between glutathione S-transferases M1 and T1 gene polymorphisms and prostate cancer risk: a systematic review and meta-analysis.Null genotypes at the GSTM1 and GSTT1 genes and the risk of benign prostatic hyperplasia: a case-control study and a meta-analysis.Association of GSTT1 gene polymorphisms with the risk of prostate cancer: an updating meta-analysis
P2860
Q28681793-38B7D58D-041D-4046-9599-05397F04612DQ33833804-13B0900C-F928-4CF1-B046-5354E3692D11Q34447716-35FA325D-11A9-411D-8AA6-EE9D47865E2FQ34494142-A88EBBB4-6E7D-4A03-A4EB-36E4A4C888DCQ34568211-6F5AFD65-728B-4956-B67C-0E9A5CB92613Q35183316-2FD91B96-2E36-4A8F-AC2C-02F2A8AB13DCQ35540054-A65E6C86-4839-4610-9FB4-8F59F2C2FEB9Q35854767-5FC21F45-D99F-4038-9413-08575E6B4460Q36758880-55416EBC-7BB2-43FB-8C42-5DA78D94BCFAQ37290556-5A6462FA-4D3A-4F10-A7FB-E3038201652EQ37587629-89EF8FE1-6C70-44EE-959A-1180764A77ADQ38118611-A3471E5F-D507-4B3C-9D93-A9D2AD2CA184Q38124272-B87D4A44-8D2D-4C4C-A656-467C452BD7D9Q44535799-07EE8528-C8D2-4DB6-B5D9-0517A76810BFQ56529319-87782B0C-59EE-4A78-B6DB-9C65B4AD853D
P2860
Are GSTM1, GSTT1 and CAG repeat length of androgen receptor gene polymorphisms associated with risk of prostate cancer in Iranian patients?
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Are GSTM1, GSTT1 and CAG repea ...... te cancer in Iranian patients?
@en
Are GSTM1, GSTT1 and CAG repea ...... te cancer in Iranian patients?
@nl
type
label
Are GSTM1, GSTT1 and CAG repea ...... te cancer in Iranian patients?
@en
Are GSTM1, GSTT1 and CAG repea ...... te cancer in Iranian patients?
@nl
prefLabel
Are GSTM1, GSTT1 and CAG repea ...... te cancer in Iranian patients?
@en
Are GSTM1, GSTT1 and CAG repea ...... te cancer in Iranian patients?
@nl
P2093
P2860
P1476
Are GSTM1, GSTT1 and CAG repea ...... te cancer in Iranian patients?
@en
P2093
Bareto Sabah Goulian
Mohsen Ayati
Sayed-Mohammad Hasheminasab
Zahra Ousati Ashtiani
P2860
P2888
P304
P356
10.1007/S12253-010-9309-Z
P577
2010-11-19T00:00:00Z